Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.

Alkner S, Bendahl PO, Ehinger A, Lövgren K, Rydén L, Fernö M

Open source

DOI
10.1371/journal.pone.0150977
Published
2016
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0150977,
  title = {Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.},
  author = {Alkner S and Bendahl PO and Ehinger A and Lövgren K and Rydén L and Fernö M},
  year = {2016},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0150977},
  url = {https://doi.org/10.1371/journal.pone.0150977}
}

RIS

TY  - JOUR
TI  - Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
AU  - Alkner S
AU  - Bendahl PO
AU  - Ehinger A
AU  - Lövgren K
AU  - Rydén L
AU  - Fernö M
PY  - 2016
JO  - PloS one
DO  - 10.1371/journal.pone.0150977
UR  - https://doi.org/10.1371/journal.pone.0150977
ER  - 

APA

S, A., PO, B., A, E., K, L., L, R., & M, F. (2016). Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.. PloS one. https://doi.org/10.1371/journal.pone.0150977

Source records